CDKL5 and epilepsy: Due to the different CDKL5 mutations and the variable X-chromosome random inactivation (XCI) in females, the phenotypic spectrum of the disease spans from milder forms—which include the possibility of autonomous walking and less severe epilepsy that is amenable to control—to severe forms featuring intractable seizures, more severe microcephaly and the absence of motor milestones.